Steven L. Merrill, M.D.; Sydney M. Finegold, M.D., F.A.C.P.; Bernard Smolens, M.D.; Alvin Davis, M.D.
This content is PDF only. Please click on the PDF icon to access.
Cephalothin is a new semisynthetic antibacterial agent structurally related to the penicillins. It is effective against penicillinase-producing staphylococci as well as other gram-positive and gram-negative organisms. More than 300 patients have been treated with cephalothin in this hospital over the past 2 years. Thirty-three of these patients were judged to have life-threatening infections, and the present report is concerned with these cases.
Twenty-three patients with well-documented pneumonia caused by Staphylococcus aureus received cephalothin in doses ranging from 2 to 6 grams intramuscularly for periods from 7 to 82 days. The patients were all males, the mean age being 64. All
Merrill SL, Finegold SM, Smolens B, et al. The Use of Cephalothin* in the Treatment of Serious Infections.. Ann Intern Med. 1965;62:1091–1092. doi: https://doi.org/10.7326/0003-4819-62-5-1091_3
Download citation file:
Published: Ann Intern Med. 1965;62(5):1091-1092.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use